Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

RVL Pharmaceuticals plc

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule			Amount Registered(1)		Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Fees to Be Paid	Equity	Ordinary Shares, $0.01 nominal value per share		457	(c)		15,451,612	$	2.07	(2)	$	31,984,836.84		0.0000927	$	2,965.00
		Total Offering Amounts									$	31,984,836.84			$	2,965.00
		Total Fees Previously Paid														—
		Total Fee Offsets														—
		Net Fee Due													$	2,965.00

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the ordinary shares offered hereby also include an indeterminate number of additional ordinary shares as may from time to time become issuable by reason of share splits, share dividends, recapitalizations or other similar transactions.

(2) Estimated at $2.07 per share, the average of the high and low prices as reported on The Nasdaq Global Select Market on August 16, 2022, for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act.